Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

Kohei Tada; Shigehisa Kitano; Hirokazu Shoji; Takashi Nishimura; Yasuhiro Shimada; Kengo Nagashima; Yoshitaka Honma; Satoru Iwasa; Natsuko Okita; Atsuo Takashima; Ken Kato; Yasuhide Yamada; Naoyuki Katayama; Narikazu Boku; Tetsuya Hamaguchi; Yuji Heike

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

【24h】

Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

机译：一线化疗对转移性结直肠癌患者治疗前免疫状况的影响无进展生存

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2015年第s2期|共页
作者
Kohei Tada; Shigehisa Kitano; Hirokazu Shoji; Takashi Nishimura; Yasuhiro Shimada; Kengo Nagashima; Yoshitaka Honma; Satoru Iwasa; Natsuko Okita; Atsuo Takashima; Ken Kato; Yasuhide Yamada; Naoyuki Katayama; Narikazu Boku; Tetsuya Hamaguchi; Yuji Heike;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients [J] . Tada Kohei, Kitano Shigehisa, Shoji Hirokazu, Cancer immunology research. . 2016,第7期

机译：化疗治疗的转移性结直肠癌患者的治疗前免疫状况与无进展生存率相关。
2. Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients [J] . Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, Cancer immunity . 2016,第7期

机译：化疗治疗的转移性结直肠癌患者的治疗前免疫状况与无进展生存率相关。
3. CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy [J] . Matsusaka S., Cao S., Hanna D. L., The pharmacogenomics journal . 2017,第6期

机译：CXCR4多态性预测，通过一线贝伐单抗化疗治疗的转移性结直肠癌患者的无进展生存
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Impact of Erythropoiesis Stimulating Agents on Survival and Risk of Venous Thromboembolism Among Patients with Colorectal Cancer Receiving Chemotherapy. [D] . Sato, Masayo. 2012

机译：红细胞生成刺激剂对接受化疗的结直肠癌患者生存率和静脉血栓栓塞风险的影响。
6. Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy [O] . Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, 2015

机译：治疗前的免疫状况对一线化疗治疗的转移性结直肠癌患者无进展生存的影响
7. Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy [O] . 2015

机译：治疗前的免疫状况对一线化疗治疗的转移性结直肠癌患者无进展生存的影响

Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅